These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17898154)

  • 41. The "albumin effect" and drug glucuronidation: bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities.
    Rowland A; Knights KM; Mackenzie PI; Miners JO
    Drug Metab Dispos; 2008 Jun; 36(6):1056-62. PubMed ID: 18362158
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional characterization of human and cynomolgus monkey UDP-glucuronosyltransferase 1A1 enzymes.
    Hanioka N; Tanabe N; Jinno H; Tanaka-Kagawa T; Nagaoka K; Naito S; Koeda A; Narimatsu S
    Life Sci; 2010 Aug; 87(7-8):261-8. PubMed ID: 20620155
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional characterization of human and cynomolgus monkey UDP-glucuronosyltransferase 1A6 enzymes.
    Hanioka N; Takeda Y; Jinno H; Tanaka-Kagawa T; Naito S; Koeda A; Shimizu T; Nomura M; Narimatsu S
    Chem Biol Interact; 2006 Dec; 164(1-2):136-45. PubMed ID: 17027947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 6-Chloro-5-[4-(1-Hydroxycyclobutyl)Phenyl]-1
    Lapham K; Lin J; Novak J; Orozco C; Niosi M; Di L; Goosen TC; Ryu S; Riccardi K; Eng H; Cameron KO; Kalgutkar AS
    Drug Metab Dispos; 2018 Dec; 46(12):1836-1846. PubMed ID: 30194276
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro glucuronidation of thyroxine and triiodothyronine by liver microsomes and recombinant human UDP-glucuronosyltransferases.
    Tong Z; Li H; Goljer I; McConnell O; Chandrasekaran A
    Drug Metab Dispos; 2007 Dec; 35(12):2203-10. PubMed ID: 17875670
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Involvement of human hepatic UGT1A1, UGT2B4, and UGT2B7 in the glucuronidation of carvedilol.
    Ohno A; Saito Y; Hanioka N; Jinno H; Saeki M; Ando M; Ozawa S; Sawada J
    Drug Metab Dispos; 2004 Feb; 32(2):235-9. PubMed ID: 14744946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of ketoconazole on glucuronidation by UDP-glucuronosyltransferase enzymes.
    Yong WP; Ramirez J; Innocenti F; Ratain MJ
    Clin Cancer Res; 2005 Sep; 11(18):6699-704. PubMed ID: 16166450
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin.
    Fisher MB; Campanale K; Ackermann BL; VandenBranden M; Wrighton SA
    Drug Metab Dispos; 2000 May; 28(5):560-6. PubMed ID: 10772635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glucuronidation of zearalenone, zeranol and four metabolites in vitro: formation of glucuronides by various microsomes and human UDP-glucuronosyltransferase isoforms.
    Pfeiffer E; Hildebrand A; Mikula H; Metzler M
    Mol Nutr Food Res; 2010 Oct; 54(10):1468-76. PubMed ID: 20397195
    [TBL] [Abstract][Full Text] [Related]  

  • 50. UDP-glucuronosyltransferase isoforms catalyzing glucuronidation of hydroxy-polychlorinated biphenyls in rat.
    Daidoji T; Gozu K; Iwano H; Inoue H; Yokota H
    Drug Metab Dispos; 2005 Oct; 33(10):1466-76. PubMed ID: 16006569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simultaneous evaluation of six human glucuronidation activities in liver microsomes using liquid chromatography-tandem mass spectrometry.
    Gagez AL; Rouguieg-Malki K; Sauvage FL; Marquet P; Picard N
    Anal Biochem; 2012 Aug; 427(1):52-9. PubMed ID: 22579593
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of cell differentiation and assay conditions on the UDP-glucuronosyltransferase activity in Caco-2 cells.
    Zhang H; Tolonen A; Rousu T; Hirvonen J; Finel M
    Drug Metab Dispos; 2011 Mar; 39(3):456-64. PubMed ID: 21098645
    [TBL] [Abstract][Full Text] [Related]  

  • 53. UDP-glucuronosyltransferase (UGT) polymorphisms affect atorvastatin lactonization in vitro and in vivo.
    Riedmaier S; Klein K; Hofmann U; Keskitalo JE; Neuvonen PJ; Schwab M; Niemi M; Zanger UM
    Clin Pharmacol Ther; 2010 Jan; 87(1):65-73. PubMed ID: 19794410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank.
    Fisher MB; Vandenbranden M; Findlay K; Burchell B; Thummel KE; Hall SD; Wrighton SA
    Pharmacogenetics; 2000 Nov; 10(8):727-39. PubMed ID: 11186135
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The UGT1A1*28 polymorphism correlates with erlotinib's effect on SN-38 glucuronidation.
    Liu Y; Ramírez J; House L; Ratain MJ
    Eur J Cancer; 2010 Jul; 46(11):2097-103. PubMed ID: 20580994
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in the human hepatoma cell line hep G2.
    Walle T; Otake Y; Galijatovic A; Ritter JK; Walle UK
    Drug Metab Dispos; 2000 Sep; 28(9):1077-82. PubMed ID: 10950852
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potential.
    Miners JO; Mackenzie PI; Knights KM
    Drug Metab Rev; 2010 Feb; 42(1):196-208. PubMed ID: 19795925
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glucuronidation of trans-resveratrol by human liver and intestinal microsomes and UGT isoforms.
    Brill SS; Furimsky AM; Ho MN; Furniss MJ; Li Y; Green AG; Bradford WW; Green CE; Kapetanovic IM; Iyer LV
    J Pharm Pharmacol; 2006 Apr; 58(4):469-79. PubMed ID: 16597364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of 3,3',4'-trihydroxyflavone and 3,6,4'-trihydroxyflavone (4'-O-glucuronidation) as the in vitro functional markers for hepatic UGT1A1.
    Wu B; Zhang S; Hu M
    Mol Pharm; 2011 Dec; 8(6):2379-89. PubMed ID: 21985641
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of UDP-glucuronosyltransferases responsible for the glucuronidation of darexaban, an oral factor Xa inhibitor, in human liver and intestine.
    Shiraga T; Yajima K; Suzuki K; Suzuki K; Hashimoto T; Iwatsubo T; Miyashita A; Usui T
    Drug Metab Dispos; 2012 Feb; 40(2):276-82. PubMed ID: 22031623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.